Literature DB >> 23772824

pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles.

Hee-Kwon Kim1, David H Thompson, Ho Seong Jang, Yong Jin Chung, Jeroen Van den Bossche.   

Abstract

Novel pH-responsive assemblies (PEG-lipid:DOPE liposomes) containing tunable and bifunctional phenyl-substituted vinyl ether (PIVE) cross-linkers were prepared. The assemblies consisted of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), acid-cleavable poly(ethylene glycol) (PEG)-conjugated lipids, pDNA, and protamine sulfate (PS). The PIVE linkage was designed to hydrolyze under acidic conditions, and the hydrolysis studies of PEG-lipid compounds containing PIVE at pH 4.2, 5.4, and 7.4 indicated that the hydrolysis rates of PIVE linker were influenced by the substitution of electron withdrawing or electron donating groups on the phenyl ring. Acid-catalyzed hydrolysis of PIVE leads to destabilization of the acid labile PEG-PIVE-lipid:DOPE liposomes via dePEGylation, thereby triggering content release. Content release assays showed that dePEGylation was highly pH-dependent and correlated with the PIVE proton affinity of the phenyl group. These results indicated that the dePEGylative triggering based on a new pH-sensitive PIVE linkage can be controlled. In vitro transfection studies on the pH-responsive assemblies containing mPEG-(MeO-PIVE)-conjugated 1,3-dioctadecyl-rac-glycerol lipids (mPEG-(MeO-PIVE])-DOG) showed higher transfection efficiency compared to that of polyethylenimine (PEI), a positive control, on HEK 293 and COS-7 cells. In addition, lower cytotoxicity of PEG-PIVE-lipid:DOPE liposomes/PS/DNA was observed in comparison to PEI. These results suggest that PEG-PIVE-lipid:DOPE liposomes can be considered as nonviral vehicles for drug and gene delivery applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23772824      PMCID: PMC3740352          DOI: 10.1021/am400977t

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  62 in total

1.  DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules.

Authors:  R Balhorn; L Brewer; M Corzett
Journal:  Mol Reprod Dev       Date:  2000-06       Impact factor: 2.609

Review 2.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

3.  Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposomes: intracellular localization and synergistic phototoxicity.

Authors:  M M Qualls; D H Thompson
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

Review 4.  Barriers to nonviral gene delivery.

Authors:  Christopher M Wiethoff; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2003-02       Impact factor: 3.534

5.  Phase behavior and aggregate structure in mixtures of dioleoylphosphatidylethanolamine and poly(ethylene glycol)-lipids.

Authors:  M Johnsson; K Edwards
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

6.  Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.

Authors:  W M Li; L Xue; L D Mayer; M B Bally
Journal:  Biochim Biophys Acta       Date:  2001-08-06

Review 7.  Delivery of molecular and cellular medicine to solid tumors.

Authors:  R K Jain
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

8.  Interactions between pH-sensitive liposomes and model membranes.

Authors:  Nill Bergstrand; Maria C Arfvidsson; Jong-Mok Kim; David H Thompson; Katarina Edwards
Journal:  Biophys Chem       Date:  2003-05-01       Impact factor: 2.352

9.  Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids.

Authors:  Junhwa Shin; Pochi Shum; David H Thompson
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

10.  Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin.

Authors:  Judit Reményi; Barbara Balázs; Sára Tóth; András Falus; Gábor Tóth; Ferenc Hudecz
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

View more
  4 in total

1.  Theranostic Nanosystems for Targeted Cancer Therapy.

Authors:  Homan Kang; Shuang Hu; Mi Hyeon Cho; Suk Ho Hong; Yongdoo Choi; Hak Soo Choi
Journal:  Nano Today       Date:  2018-11-16       Impact factor: 20.722

2.  Conjugation Chemistry-Dependent T-Cell Activation with Spherical Nucleic Acids.

Authors:  Kacper Skakuj; Shuya Wang; Lei Qin; Andrew Lee; Bin Zhang; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2018-01-22       Impact factor: 15.419

Review 3.  Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.

Authors:  Zhe Ren; Tao Liao; Cao Li; Ying Kuang
Journal:  Materials (Basel)       Date:  2022-07-31       Impact factor: 3.748

Review 4.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

Authors:  Elmira Heidarli; Simin Dadashzadeh; Azadeh Haeri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.